Torrent Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Torrent Pharma - Not Just Healthcare But Lifecare
One of their notable products is OLMESARTAN MEDOXOMIL USP, with a corresponding US DMF Number 24180.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2013, and payment made on September 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II